Clinical trials for Cerebrotendinous xanthomatosis
34 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPHASE1, PHASE2NCT07510802Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBCBeijing Biotech
- RECRUITINGPhase 1NCT07162038Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell TransplantationNational Cancer Institute (NCI) · PI: Christopher G Kanakry, M.D.
- RECRUITINGN/ANCT06790225Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)Esbjerg Hospital - University Hospital of Southern Denmark
- RECRUITINGPhase 2NCT05909059CAR T-cell Therapy in Patients With Renal DysfunctionNorthside Hospital, Inc.
- RECRUITINGPhase 2NCT06042569Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY TrialCity of Hope Medical Center · PI: Thanh Nga E Doan, MD
- RECRUITINGPHASE1, PHASE2NCT06594640R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell LymphomaInstitute of Hematology & Blood Diseases Hospital, China · PI: Lugui Qiu, Professor
- RECRUITINGPhase 1NCT05748197A Study of ADCLEC.syn1 in People With Acute Myeloid LeukemiaMemorial Sloan Kettering Cancer Center · PI: Jae Park, MD
- RECRUITINGPhase 3NCT05883852EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast CancerFudan University
- ACTIVE NOT RECRUITINGPhase 1NCT05627323CAR T Cells in Patients With MMP2+ Recurrent or Progressive GlioblastomaChimeric Therapeutics
- RECRUITINGN/ANCT05876065Capecitabine and Cyclophosphamide (XC) as Maintenance Therapy for Advanced Breast CancerWenjin Yin · PI: Wenjin Yin, M.D.
- RECRUITINGN/ANCT05929092TFBC Combined With UCBT in the Treatment of High-risk Malignant Hematological DiseasesThe First Affiliated Hospital of Soochow University
- RECRUITINGPhase 2NCT06005870Zanubrutinib Combined With R-CHOP in the Treatment of Newly Diagnosed DLBCL With p53 Protein ExpressionHuazhong University of Science and Technology · PI: Liling Zhang, M.D
- ACTIVE NOT RECRUITINGPhase 2NCT05621759Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHDNYU Langone Health · PI: Mohammad Maher Abdul Hay
- ACTIVE NOT RECRUITINGPhase 2NCT06019507A Study of TCD601 in the Induction of Tolerance in de Novo Liver TransplantationITB-Med LLC · PI: Kellie Kennon, BSN
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05275777A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast CancerNational University Hospital, Singapore · PI: Soo Chin Lee
- ACTIVE NOT RECRUITINGPhase 2NCT05256537Fludarabine and Total Body Irradiation 800 Centigray (cGy) or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacrolimus, Without Mycophenolate MofetilRonald Paquette · PI: Ronald Paquette, MD
- ACTIVE NOT RECRUITINGPhase 2NCT04980222A Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell LymphomaHoffmann-La Roche · PI: Clinical Trials
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05201248A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Therapies in Adult Participants in China With B-Cell Non-Hodgkin LymphomaGenmab · PI: ABBVIE INC.
- RECRUITINGPhase 1NCT05052528Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell LymphomaMehrdad Abedi, MD · PI: Mehrdad Abedi
- ACTIVE NOT RECRUITINGPhase 2NCT04392037Iberdomide Combined With Low-dose Cyclophosphamide and DexamethasoneAmsterdam UMC, location VUmc · PI: N.W.C.J van de Donk, Prof. MD PhD
- ACTIVE NOT RECRUITINGPhase 3NCT04529772A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312)Acerta Pharma BV
- RECRUITINGPhase 2NCT03971045Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast CancerEuropean Institute of Oncology
- RECRUITINGPhase 2NCT04237623GM-CSF With Post-Transplant CyclophosphamideNorthside Hospital, Inc. · PI: Melhem Solh, MD
- RECRUITINGPHASE1, PHASE2NCT03658785Immunotherapy for the Treatment of Advanced Solid TumorTongji Hospital · PI: Hui Wang, MD
- ACTIVE NOT RECRUITINGPhase 1NCT04214392Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive GlioblastomaCity of Hope Medical Center · PI: Behnam Badie
- RECRUITINGPhase 2NCT03980002A Prospective Multicenter Phase 2 Study of FCR/BR Alternating With Ibrutinib in Treatment-naive Patients With CLLInstitute of Hematology & Blood Diseases Hospital, China · PI: Zengjun Li
- ACTIVE NOT RECRUITINGPhase 1NCT03655002IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver CancerCity of Hope Medical Center · PI: Daneng Li
- ACTIVE NOT RECRUITINGPhase 2NCT04172259ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBCSun Yat-sen University · PI: Wen Xia, MD
- ACTIVE NOT RECRUITINGPhase 2NCT02406222Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM)University of Leeds · PI: Martin Kaiser, Dr
- ACTIVE NOT RECRUITINGPhase 3NCT02455141Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast CancerShanghai Jiao Tong University School of Medicine · PI: Kunwei Shen, professor
- ACTIVE NOT RECRUITINGPhase 1NCT02498912Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid TumorsMemorial Sloan Kettering Cancer Center · PI: Roisin O'Cearbhaill, MD
- ACTIVE NOT RECRUITINGPhase 2NCT01864109Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing SarcomaMemorial Sloan Kettering Cancer Center · PI: Emily Slotkin, MD
- ACTIVE NOT RECRUITINGPhase 2NCT01750073Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast CancerUniversity of Nebraska · PI: Amulya C Yellala, MD
- ACTIVE NOT RECRUITINGPhase 1NCT01351909Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast CancerNational Cancer Institute (NCI) · PI: Joseph A Sparano